Melanotan 1 injections are tanning peptides sold online, but no injectable form is FDA-approved. Learn how afamelanotide works, dosing risks, and safety.
Melanotan 1 injections are unapproved peptide products sold online for cosmetic tanning, and no injectable form of melanotan 1 is FDA-approved for human use in the United States. The prescription drug Scenesse (afamelanotide) is an implant approved only for a rare light-sensitivity disorder called erythropoietic protoporphyria, not for tanning. Self-injecting gray-market vials carries real risks, and no established safe dose exists for cosmetic use.
What Melanotan 1 Actually Is
Melanotan 1, also known as afamelanotide, is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone. It binds mainly to the MC1R receptor on melanocytes — the cells that produce pigment — and signals them to build more eumelanin, the dark pigment behind a tan.
Because it is relatively selective for MC1R, it is often described as the "tanning-only" peptide. Many users compare melanotan 1 with melanotan 2, but the two peptides behave very differently at the receptor level.
Melanotan 1 still requires ultraviolet light to produce visible darkening. The peptide raises pigment production; UV exposure is what drives the color change, and a cosmetic tan does not equal protection from sun damage.
Is Melanotan 1 Legal or FDA-Approved?
Melanotan 1 is not approved by the FDA as an injectable drug for any purpose. The only approved afamelanotide product in the United States is Scenesse, a 16 mg subcutaneous implant placed every two months for confirmed erythropoietic protoporphyria.
- Selling melanotan 1 for human use is illegal in the United States.
- "Research chemical — not for human use" labels are a legal workaround, not a safety guarantee.
- US customs routinely seizes imported peptide vials.
- No pharmacy or clinic can legally dispense melanotan 1 injections for tanning.
Buying overseas also means no quality control. Independent testing of tanning peptides has repeatedly found vials with wrong concentrations, bacterial contamination, and unidentified compounds.
Melanotan 1 vs Melanotan 2 at a Glance
The two peptides are frequently confused, but their receptor activity and approval status are not the same.
| Feature | Melanotan 1 (afamelanotide) | Melanotan II (MT2) |
|---|---|---|
| Primary receptors | MC1R (pigment cells) | MC1R, MC3R, MC4R, MC5R |
| Reported effects | Gradual tanning with UV exposure | Tanning plus reported appetite and libido changes |
| FDA status | Implant approved for EPP only | Not approved for any human use |
| Reported half-life | Weeks of release from the implant | Often cited at roughly 30–60 minutes |
| Typical market form | Prescription implant | Gray-market lyophilized vials |
People searching for melanotan ii half life usually find forum figures rather than controlled human data. Reported melanotan ii libido effects — increased arousal and spontaneous erections — are widely discussed online, and priapism from MT2 is a documented medical emergency that requires immediate care.
Reported Dosing and Injection Practices
There are no official dosing guidelines for melanotan 1 injections because the product is unapproved. Online forums circulate user-made protocols that involve mixing lyophilized powder with bac water for peptide injections and then injecting under the skin with an insulin syringe. Those protocols vary widely between posters, which makes dosing errors and contamination common.
Many of the same marketplaces that sell melanotan vials also promote aod 9604 injections and other unapproved peptides. The supply chains are typically the same unverified overseas operations, and sterility paperwork is often fabricated.
Reusing needles, sharing vials, and injecting powder that was never tested for human use all raise the risk of infection and injection-site abscesses. No healthcare professional can responsibly supervise an unapproved tanning protocol.
Side Effects and Safety Concerns
Reported reactions range from annoying to serious, and long-term data on cosmetic use does not exist.
- Nausea, facial flushing, headache, and fatigue after injection
- Darkening of existing moles and growth of new nevi
- Concern among dermatologists about melanoma risk with repeated UV exposure
- Injection-site pain, redness, and infection
- Blood pressure changes and, with MT2, priapism
- Unknown effects on immune signaling and hormone pathways
Any new, changing, or irregular mole should be evaluated by a dermatologist, especially after peptide use. Melanotan 1 is not a substitute for sun protection, and a tan from any source does not prevent skin cancer.
Safer Ways to Handle Tanning and Sun Sensitivity
If the goal is a darker appearance, FDA-approved sunless tanners containing DHA offer color without UV exposure or injections. If the goal is managing a diagnosed light-sensitivity disorder, Scenesse is prescribed and monitored by specialists who track liver enzymes and skin changes.
Anyone considering melanotan 1 injections should talk with a healthcare professional first, particularly people with a personal or family history of melanoma. The safest takeaway is simple: melanotan 1 is not FDA-approved for cosmetic tanning in the United States, and no injectable version of it is legal to sell for human use.
Frequently Asked Questions
Is melanotan 1 FDA-approved?
No. Melanotan 1 is not FDA-approved as an injectable drug for any use. The only approved afamelanotide product in the US is Scenesse, a subcutaneous implant limited to patients with erythropoietic protoporphyria, a rare inherited condition that causes severe sun sensitivity.
What is the difference between melanotan 1 and melanotan 2?
Melanotan 1 (afamelanotide) targets mainly the MC1R receptor involved in pigment production, while melanotan II also activates receptors linked to appetite, libido, and blood pressure. Melanotan II is not approved for any human use, and it is associated with additional side effects such as spontaneous erections and priapism.
What are the side effects of melanotan 1 injections?
Reported side effects include nausea, flushing, headache, fatigue, injection-site reactions, and darkening of existing moles or new moles. Because long-term human safety data are lacking, dermatologists also raise concerns about melanoma risk, especially when the peptide is combined with tanning-bed or sun exposure.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.